NovoCure
NVCR
NVCR
223 hedge funds and large institutions have $1.45B invested in NovoCure in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 78 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $1.59B → $1.45B (-$140M)
19% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 78
27% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 33
Holders
223
Holding in Top 10
2
Calls
$25.1M
Puts
$8.17M
Top Buyers
| 1 | +$31.3M | |
| 2 | +$23.7M | |
| 3 | +$17.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.2M |
| 5 |
BlackRock
New York
|
+$10.1M |
Top Sellers
| 1 | -$59M | |
| 2 | -$14.6M | |
| 3 | -$8.08M | |
| 4 |
Two Sigma Investments
New York
|
-$7.88M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$6.46M |